Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
There is a potential therapeutic potential of targeting glucocerebrosidase in the treatment of Morbus Parkinson / Parkinson's Disease (PD)-
The link between Gaucher disease and Morbus Parkinson / Parkinson's Disease (PD) was initially observed in clinical settings. It was noted that individuals with Gaucher disease and their carrier relatives showed a higher incidence of Morbus Parkinson / Parkinson's Disease (PD). Presently, mutations in the glucocerebrosidase (GBA1) gene are identified as the most prevalent genetic risk factor for both Parkinson’s disease and dementia with Lewy bodies. There is …